Long-term seizure control after resection of supratentorial cavernomas: A retrospective single-center study in 53 patients

Neurosurgery

Volumn 63, Issue 5, 2008, Pages 888-896

  Stavrou, Ioannis ^a   Baumgartner, Christoph ^b   Frischer, Josa M ^c   Trattnig, Siegfried ^a   Knosp, Engelbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital   (Austria)

^c Medical University of Vienna   (Austria)

Author keywords

Cavernoma; Epilepsy; Follow up; Hemosiderin; Outcome

Indexed keywords

ANTICONVULSIVE AGENT; HEMOSIDERIN;

ADULT; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; CORPUS CAVERNOSUM; DEPRESSION; DISEASE CLASSIFICATION; DISEASE DURATION; EPILEPSY; FATIGUE; FEMALE; FOLLOW UP; GLIOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUPRATENTORIAL CAVERNOMA; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GLIOSIS; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HEMOSIDERIN; HUMANS; MALE; MICROSURGERY; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SEX FACTORS; SUPRATENTORIAL NEOPLASMS; TIME; TIME FACTORS; TREATMENT OUTCOME;

EID: 57649135124     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000327881.72964.6E     Document Type: Article

References (35)

1. Anonymous: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 22:489-501, 1981.
2. Awad I, Jabbour P: Cerebral cavernous malformations and epilepsy. Neurosurg Focus 21:e7, 2006.
3. Awad IA, Robinson JR: Cavernous malformations and epilepsy, in Awad IA, Barrow DL (eds): Cavernous Malformations. Park Ridge, AANS, 1993, pp 49-63.
4. Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermam F, Siegel AM: Seizure outcome after resection of supratentorial cavernous malformations: A study of 168 patients. Epilepsia 48:559-563, 2007.
5. Baumann CR, Schuknecht B, Lu Russo G, Cossu M, Citterio A, Andermann F, Siegel AM: Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47:563-566, 2006.
6. Berg AT: Defining intractable epilepsy. Adv Neurol 97:5-10, 2006.
7. Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E: Supratentorial cavernous malformations and epilepsy: Seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99:179-183, 1997.
8. Casazza M, Broggi G, Franzini A, Avanzini G, Spreafico R, Bracchi M, Valentini MC: Supratentorial cavernous angiomas and epileptic seizures: Preoperative course and postoperative outcome. Neurosurgery 39:26-34, 1996.
9. Cohen DS, Zubay GP, Goodman RR: Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83:237-242, 1995.
10. Cosgrove GR: Occult vascular malformations and seizures. Neurosurg Clin N Am 10:527-535, 1999.
11. Engel J Jr: Outcome with respect to epileptic seizures, in Engel J Jr (ed): Surgical Treatment of the Epilepsies. New York, Raven Press, 1987, pp 553-579.
12. Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM: Outcome with respect to epileptic seizures, in Engel J Jr (ed): Surgical Treatment of the Epilepsies. New York, Raven Press, 1993, ed 2, pp 609-622.
13. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr: Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470-472, 2005.
14. Folkersma H, Mooij JJ: Follow-up of 13 patients with surgical treatment of cerebral cavernous malformations: Effect on epilepsy and patient disability. Clin Neurol Neurosurg 103:67-71, 2001.
15. French JA: Refractory epilepsy: Clinical overview. Epilepsia 48 [Suppl 1]:3-7, 2007.
16. Frischer JM, Pipp I, Stavrou I, Trattnig S, Hainfellner JA, Knosp E: Cerebral cavernous malformations: Congruency of histopathological features with the current clinical definition. J Neurol Neurosurg Psychiatry 79:783-788, 2008.
17. Hammen T, Romstöck J, Dörfler A, Kerling F, Buchfelder M, Stefan H: Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: A study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16:248-253, 2007.
18. Hsu FPK, Rigamonti D, Huhn SL: Epidemiology of cavernous malformations, in Awad IA, Barrow DL (eds): Cavernous Malformations. Park Ridge, AANS, 1993, pp 13-23.
19. Kraemer DL, Awad IA: Vascular malformations and epilepsy: Clinical considerations and basic mechanisms. Epilepsia 35 [Suppl 6]:S30-S43, 1994.
20. Kraemer DKA, Pizzonia JH: How do vascular lesions cause epilepsy? in Kotagal P, Lüders HO (eds): The Epilepsies, Etiology and Prevention. New York, Raven Press, 1999, pp 385-390.
21. Kraemer DL, Griebel ML, Lee N, Friedman AH, Radtke RA: Surgical outcome in patients with epilepsy with occult vascular malformations treated with lesionectomy. Epilepsia 39:600-607, 1998.
22. Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 342:314-319, 2000.
23. Lüders H, Murphy D, Awad I, Wyllie E, Dinner DS, Morris HH 3rd, Rothner AD: Quantitative analysis of seizure frequency 1 week and 6, 12, and 24 months after surgery of epilepsy. Epilepsia 35:1174-1178, 1994.
24. Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM: Supratentorial cavernous haemangiomas and epilepsy: A review of the literature and case series. J Neurol Neurosurg Psychiatry 66:561-568, 1999.
25. Piepgras DG, Sundt TM Jr, Ragoowansi AT, Stevens L: Seizure outcome in patients with surgically treated cerebral arteriovenous malformations. J Neurosurg 78:5-11, 1993.
26. Rankin J: Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2:200-215, 1957.
27. Robinson JR, Awad IA, Little JR: Natural history of the cavernous angioma. J Neurosurg 75:709-714, 1991.
28. Satoh H, Matsui K: Electrical and mechanical modulations be oxygen-derived free-radical generating systems in guinea-pig heart muscles. J Pharm Pharmacol 49:505-510, 1997,
29. Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Haut S, Langfitt JT, Walczak TS, Devinsky O; Multicenter Study of Epilepsy Surgery: Health-related quality of life over time since resective epilepsy surgery. Ann Neurol 62:327-334, 2007.
30. Stefan H, Hammen T: Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 110:393-397, 2004.
31. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607, 1988.
32. Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Lüders H, Pedley TA; Commission on Neurosurgery of the International League Against Epilepsy (ILAE): ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 42:282-286, 2001.
33. Wyllie E, Lüders H, Morris HH 3rd, Lesser RP, Dinner DS, Hahn J, Estes ML, Rothner AD, Erenberg G, Cruse R, Friedman D: Clinical outcome after complete or partial cortical resection for intractable epilepsy. Neurology 37:1634-1641, 1987.
34. Yeh HS, Tew JM Jr, Gartner M: Seizure control after surgery on cerebral arteriovenous malformations. J Neurosurg 78:12-18, 1993.
35. Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ: Seizure control following surgery in supratentorial cavernous malformations: A retrospective study in 77 patients. Acta Neurochir (Wien) 138:672-677, 1996.